Effects of secondary prophylaxis started in adolescent and adult haemophiliacs
暂无分享,去创建一个
P. Mannucci | M. Franchini | C. Santoro | A. Coppola | E. Zanon | A. Tagliaferri | G. Rivolta | P. Iannaccaro | P. Radossi | G. Rossetti | G. Feola | P. Mannucci | A. Dragani | G. F. RIVOLTA
[1] L. Mantovani,et al. Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.
[2] C. Hermans,et al. Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.
[3] F. Lafeber,et al. Prophylactic treatment for prevention of joint disease in hemophilia--cost versus benefit. , 2007, The New England journal of medicine.
[4] Alan R. Cohen,et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.
[5] C. Hay. Prophylaxis in adults with haemophilia , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.
[6] M. Franchini,et al. Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs , 2006, Thrombosis and Haemostasis.
[7] A. Iorio,et al. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. , 2006, The Cochrane database of systematic reviews.
[8] K. Fischer,et al. Can long‐term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands , 2005, British journal of haematology.
[9] R. Ljung,et al. Changing pattern of care of boys with haemophilia in western European centres , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.
[10] E. Remor,et al. Disease‐specific quality‐of‐life measurement tools for haemophilia patients , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.
[11] L. Valentino. Secondary prophylaxis therapy: what are the benefits, limitations and unknowns? , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.
[12] V. Blanchette,et al. Development of a health‐related quality of life measure for boys with haemophilia: the Canadian Haemophilia Outcomes – Kids Life Assessment Tool (CHO‐KLAT) , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.
[13] K. Fischer,et al. Health‐related quality of life as outcome parameter in haemophilia treatment , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.
[14] D. Grobbee,et al. Prophylactic versus on‐demand treatment strategies for severe haemophilia: a comparison of costs and long‐term outcome , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.
[15] A. Miners,et al. Experience of prophylaxis treatment in children with severe haemophilia , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.
[16] P. Giangrande,et al. Clinical outcomes and resource utilization associated with haemophilia care in Europe , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.
[17] F. Beek,et al. Long‐term outcome of individualized prophylactic treatment of children with severe haemophilia , 2001, British journal of haematology.
[18] Mannucci,et al. Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.
[19] C. Sabin,et al. Assessing the effectiveness and cost‐effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand's disease , 1998, Journal of internal medicine.
[20] J. Avorn,et al. Prophylactic Use of Factor VIII: an Economic Evaluation , 1998, Thrombosis and Haemostasis.
[21] J. Goldman,et al. Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion , 1997, Transfusion.
[22] H. Pettersson,et al. Haemophilia prophylaxis in young patients–a long‐term follow‐up , 1997, Journal of internal medicine.
[23] S. Böttger,et al. Radiological score in paediatric haemophilic patients with early and late onset of factor VIII-prophylaxis. , 1996, Thrombosis and haemostasis.
[24] K. Khair,et al. The impact of prophylactic treatment on children with severe haemophilia , 1996, British journal of haematology.
[25] P. Mannucci,et al. Modern treatment of haemophilia. , 1995, Bulletin of the World Health Organization.
[26] H. Pettersson,et al. A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs , 1994, Journal of internal medicine.
[27] M. Gilbert. Prophylaxis: musculoskeletal evaluation. , 1993, Seminars in hematology.
[28] H. Pettersson,et al. Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.
[29] J. Oldenburg,et al. Long-term therapy and on-demand treatment of children and adolescents with severe haemophilia A: 12 years of experience. , 1992, Haemostasis.
[30] H. Pettersson,et al. A radiologic classification of hemophilic arthropathy. , 1980, Clinical orthopaedics and related research.